Reduce regulatory risk and prepare for a successful marketing application submission.
Watch the Trailer:
Session Overview
Preparing a marketing application requires more than assembling documents. It takes early planning, ongoing readiness assessments, and a proactive approach to identifying and addressing potential risks before submission. As regulatory expectations continue to evolve, sponsors that begin preparing early are better positioned to avoid delays, strengthen compliance, and accelerate the path to approval.
In this on-demand webinar, regulatory strategy and operations experts share practical approaches for assessing marketing application readiness throughout late-stage drug development. Learn how to evaluate critical data across CMC, nonclinical, clinical, and regional regulatory requirements, develop risk-based remediation plans, and align regulatory strategy with operational execution to support a technically compliant, on-time NDA or MAA submission.
What You’ll Learn:
- When to begin submission readiness activities and why early planning matters
- How to identify and prioritize gaps across regulatory, CMC, nonclinical, and clinical documentation
- Strategies for navigating US and EU submission requirements, including upcoming eCTD 4.0 changes
- How regulatory strategy and operations work together to support successful NDA and MAA submissions
Complete the form to watch the session on demand.
Ready to get started? So are we.
Drop us a line to learn more about how we can help.